FDA Approved: KENGREAL — Supplemental Application (Chiesi USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application for KENGREAL (cangrelor) from Chiesi USA, Inc., resulting in an updated labeling for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Coronary Syndrome
• Ischemic Heart Disease
• Myocardial Infarction

Drugs mentioned

• Kengreal (cangrelor)

Snippet

SUPPL AP for KENGREAL (CANGRELOR)